VAERS reports by lot

Moderna COVID-19 lot 026L2OA: VAERS reports

41 VAERS reports list lot 026L2OA as a Moderna COVID-19 vaccine, received between 2020-12-30 and 2023-01-13. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
41
Reports
5%
Marked serious
0
With a death outcome
7
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction4826%
General / Systemic (non-local)4022%
Neurological3016%
Cardiac / Cardiovascular2916%
Allergic / Anaphylactic95%
Musculoskeletal84%
Gastrointestinal63%
Dermatological (non-injection-site)63%
Respiratory53%
Autoimmune / Immune-mediated21%
Thrombotic / Hematological11%
Psychiatric / Neuropsychiatric11%
Reproductive / Menstrual11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Georgia6
Massachusetts4
Virginia4
Indiana4
New York3
Illinois3
Pennsylvania3
Ohio2
Connecticut2
Rhode Island2
Florida2
Minnesota1

Reports by month received

2020-122
2021-0126
2021-024
2021-031
2021-062
2021-085
2023-011

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.